The ␤-isoform of protein kinase C (PKC) has paradoxically been suggested to be important for both insulin action and insulin resistance as well as for contributing to the pathogenesis of diabetic complications. Presently, we evaluated the effects of knockout of the PKC␤ gene on overall glucose homeostasis and insulin regulation of glucose transport. To evaluate subtle differences in glucose homeostasis in vivo, knockout mice were extensively backcrossed in C57BL/6 mice to diminish genetic differences other than the absence of the PKC␤ gene. PKC␤ Ϫ/Ϫ knockout offspring obtained through this backcrossing had 10% lower blood glucose levels than those observed in PKC␤ ϩ/ϩ wild-type offspring in both the fasting state and 30 min after ip injection of glucose despite having similar or slightly lower serum insulin levels. Also, compared with commercially obtained C57BL/ 6 -129/SV hybrid control mice, serum glucose levels were similar, and serum insulin levels were similar or slightly lower, in C57BL/6 -129/SV hybrid PKC␤ knockout mice in fasting and fed states and after ip glucose administration. In keeping with a tendency for slightly lower serum glucose and/or insulin levels in PKC␤ knockout mice, insulin-stimulated 2-deoxyglucose (2-DOG) uptake was enhanced by 50 -100% in isolated adipocytes; basal and insulin-stimulated epitope-tagged GLUT4 translocations in adipocytes were increased by 41% and 27%, respectively; and basal 2-DOG uptake was mildly increased by 20 -25% in soleus muscles incubated in vitro. The reason for increased 2-DOG uptake and/or GLUT4 translocation in these tissues was uncertain, as there were no significant alterations in phosphatidylinositol 3-kinase activity or activation or in levels of GLUT1 or GLUT4 glucose transporters or other PKC isoforms. On the other hand, increases in 2-DOG uptake may have been partly caused by the loss of PKC␤1, rather than PKC␤2, as transient expression of PKC␤1 selectively inhibited insulin-stimulated translocation of epitope-tagged GLUT4 in adipocytes prepared from PKC␤ knockout mice. Our findings suggest that 1) PKC␤ is not required for insulinstimulated glucose transport; 2) overall glucose homeostasis in vivo is mildly enhanced by knockout of the PKC␤ gene; 3) glucose transport is increased in some tissues in PKC␤ knockout mice; and 4) increased glucose transport may be partly due to loss of PKC␤1, which negatively modulates insulin-stimulated GLUT4 translocation. (Endocrinology 140: 4470 -4477, 1999) 
50 -100% in isolated adipocytes; basal and insulin-stimulated epitope-tagged GLUT4 translocations in adipocytes were increased by 41% and 27%, respectively; and basal 2-DOG uptake was mildly increased by 20 -25% in soleus muscles incubated in vitro. The reason for increased 2-DOG uptake and/or GLUT4 translocation in these tissues was uncertain, as there were no significant alterations in phosphatidylinositol 3-kinase activity or activation or in levels of GLUT1 or GLUT4 glucose transporters or other PKC isoforms. On the other hand, increases in 2-DOG uptake may have been partly caused by the loss of PKC␤1, rather than PKC␤2, as transient expression of PKC␤1 selectively inhibited insulin-stimulated translocation of epitope-tagged GLUT4 in adipocytes prepared from PKC␤ knockout mice. Our findings suggest that 1) PKC␤ is not required for insulinstimulated glucose transport; 2) overall glucose homeostasis in vivo is mildly enhanced by knockout of the PKC␤ gene; 3) glucose transport is increased in some tissues in PKC␤ knockout mice; and 4) increased glucose transport may be partly due to loss of PKC␤1, which negatively modulates insulin-stimulated GLUT4 translocation. (Endocrinology 140: 4470 -4477, 1999) T HE GENE ENCODING protein kinase C-␤ (PKC␤) is alternatively spliced to yield PKC␤1 and PKC␤2, which differ in their C-terminus. Of these splice products, the role of PKC␤2 during insulin stimulation of glucose transport is controversial, but of critical importance, as it has also been reported to play an important role in causing insulin resistance (1) and diabetic complications (2) . With respect to the controversy on the role of PKC␤2 in insulin action, it was reported in studies of L6 myotubes (3) that expression of a C-terminus-truncated, kinase-defective form of PKC␤2 and a semiselective PKC␤ inhibitor completely inhibited insulinstimulated glucose transport; it was therefore postulated that PKC␤ is required in this action of insulin (3) . Other findings in L6 myotubes, however, suggested that PKC␤2 as well as its alternative splice product, PKC␤1, and other diacylglycerol (DAG)-sensitive PKCs are not required for insulin-stimulated glucose transport (4) . In the latter study, a specific and potent inhibitor of PKC␤2 and PKC␤1 and complete or nearly complete down-regulation of PKC␤2, PKC␤1, and other DAG-sensitive PKCs failed to inhibit insulin-stimulated glucose transport (4) . Similarly, findings in studies of stably transfected 3T3/L1 cells (5) and of various PKC inhibitors and PKC down-regulation in rat adipocytes (6) , suggested that atypical, DAG-insensitive PKCs, such as PKC and/or PKC, but not PKC␤, PKC␣, PKC␦, or PKC⑀, may be required for insulin-stimulated glucose transport. Unfortunately, these studies did not convincingly answer the question of whether there is a requirement for PKC␤2 during insulin stimulation of glucose transport. For example, allegedly specific inhibitors and expression of large amounts of the above-mentioned truncated PKC␤2 or, for that matter, any PKC could have produced nonspecific inhibitory effects; also, in studies in which PKC inhibitors and phorbol esterinduced PKC down-regulation were used, it is not certain that there was full inhibition or sufficient depletion of all DAG-sensitive PKC isoforms that may be required for insulin effects on glucose transport. Accordingly, other experimental approaches are needed to answer the question of whether a specific PKC isoform is required for insulin stimulation of glucose transport.
The importance of the question of the role of PKC␤2 during insulin stimulation of glucose transport is underscored by the fact that PKC␤2 has been suggested to play a role in causing, and inhibitors of PKC␤2 appear to be useful for preventing or diminishing, eye and renal complications of diabetes mellitus in laboratory animals (2) : indeed, such inhibitors of PKC␤2 are currently being used in clinical trials in humans. In addition, the overexpression of PKC␤2 and PKC␤1 leads to inhibition of insulin signaling mechanisms (1), and some investigators have suggested that excessive activity of these and other DAG-sensitive PKCs (presumably resulting from excessive levels of glucose, fatty acids or insulin itself, e.g. in certain diabetic states) may impair insulin signaling at the level of the insulin receptor (7) (8) (9) or insulin receptor substrate-1 (IRS-1)-dependent activation of phosphatidylinositol (PI) 3-kinase (10), and thereby cause insulin resistance (11) . As the latter postulation further implies that inhibition of PKC␤2 or other DAG-sensitive PKCs may, in fact, improve not only diabetic complications, but also clinical insulin resistance, it becomes all the more important to have a better understanding of the importance of various PKC isoforms in insulin action, particularly in a physiological setting and as related to glucose transport. Presently, we addressed this question by examining overall glucose homeostasis in vivo and glucose transport responses in insulinsensitive tissues of mice in which the PKC␤ gene, including both of its splice products, PKC␤1 and PKC␤2, was knocked out by homologous recombination.
Materials and Methods Mice
The PKC␤ gene was knocked out by homologous recombination as described previously (12) . For most experiments, (unless stated otherwise), we used male homozygote PKC␤ knockout mice (PKC␤ Ϫ/Ϫ ) that were offspring of F 2 hybrids of C57BL/6 ϫ 129/SV mice, obtained by intercrossing at the fifth to eighth generation; as controls, we generally used male C57BL/6 -129/SV F 1 hybrids obtained from The Jackson Laboratory (Bar Harbor, ME), although in a few experiments (as indicated) we also used pure strains of C57BL/6 and 129/SV control mice, also obtained from The Jackson Laboratory. In a few experiments (see Table 1 ), to minimize genetic differences other than the absence of the PKC␤ gene, we used offspring of heterozygous C57BL/6 mice (PKC␤ ϩ/Ϫ ) that were derived by repeated backcrossing with normal C57BL/6 mice: this approach was not extensively used, as it was difficult to obtain sufficient numbers of both PKC␤ Ϫ/Ϫ and PKC␤ ϩ/ϩ male mice for direct comparisons. All mice were housed in an environmentally controlled environment with 12-h light, 12-h dark cycles and were fed the same standard chow for at least 2 weeks before experimentation. The mice used in all studies were sexually mature males or, in a few instances (where indicated), nonpregnant females that were 8 -12 weeks of age. Body weights of control and PKC␤ knockout mice were not significantly different, and except for coat color, there were no obvious somatic differences between PKC␤ knockout and various control mice.
Tissue incubations
As described previously (6), adipocytes were obtained from epididymal fat pads by collagenase digestion, suspended (8% cell vol/total cell plus buffer volume) in glucose-free Krebs-Ringer phosphate (KRP) buffer containing 1% BSA, and 270-l aliquots were placed in plastic tubes and then treated for 30 min with or without varying doses of insulin (Eli Lilly & Co., Indianapolis, IN), after which, uptake of [ 3 H]2-deoxyglucose (2-DOG; 0.1 mm; New England Nuclear Corp., Boston, MA) was measured over a 1-min period. As described previously (13) , soleus muscles were ligated at each end, maintained at resting length during incubation in glucose-free KRP medium, and treated for 30 min with or without 100 nm insulin, after which the uptake of [ 3 H]2-DOG (0.1 mm; along with l-[
14 C]glucose to correct for nonspecific trapping) was measured over a 10-min period.
Adipocyte transfections and assay of epitope-tagged GLUT4 translocation
Adipocytes were transiently transfected using electroporation as described previously (6) with pCIS2 (provided by Drs. Michael Quon and Simeon Taylor, NIH, Bethesda, MD), which contained a cytomegalovirus promoter and enhancer with a generic intron located upstream of the multiple cloning site, and a complementary DNA (cDNA) encoding hemagglutinin antigen (HA)-tagged (in an exofacial loop) GLUT4 (3 g DNA/0.8 ml adipocyte suspension), with or without (as indicated) pTB701 (7 g DNA/0.8 ml adipocyte suspension) containing no insert (i.e. vector only) or cDNA insert encoding PKC␤1 or PKC␤2. After overnight incubation to allow time for expression (verified by the appearance of immunoreactive PKC␤1, PKC␤2, and HA-GLUT4), cells were suspended in glucose-free KRP buffer and treated for 30 min with or without 10 nm insulin. Cell surface HA epitope (i.e. translocation) was then measured by stopping the reaction with 2 mm KCN, followed by incubation first with mouse monoclonal anti-HA antibody (Babco, Berkeley, CA) and second with 125 I-labeled antimouse IGG antiserum (Amersham Pharmacia Biotech, Arlington Heights, IL), as previously described (6) . The expression of immunoreactive HA-GLUT4 was comparable in wild-type control cells and PKC␤ knockout cells transfected with vector alone or vector containing cDNA encoding PKC␤1 and PKC␤2. Expression of PKC␤1 and PKC␤2 in transfected cells was documented both with isoform-specific antisera that target unique Cterminal epitopes and by an antiserum that targets an internal epitope common to both PKC␤1 and PKC␤2.
In vivo studies
Glucose tolerance tests were conducted in overnight fasted, unanesthetized mice by injecting 2 mg glucose/g BW, ip; tail blood was sampled at 0, 10, 30, and 60 min. THe effects of insulin on [ 3 H]2-DOG uptake in the gastrocnemius muscle in vivo were studied essentially as described previously (14) ; overnight fasted mice were injected im with 1 Ci 14 C]glucose with or without 0.2 U insulin. After 15 min, the mice were killed, and samples of serum and muscle were obtained to determine the specific activity of serum 2-DOG (i.e. counts per min of 3 H in 2-DOG relative to the total glucose level) and uptake of 3 H and 14 C in the gastrocnemius muscles. Nonspecific trapping of [ 3 H]2-DOG in muscles was determined by examining the level of l-[
14 C]glucose in the sample. Overall uptake of 2-DOG in muscle was then calculated using the specific activity of [ 3 H]2-DOG in the plasma.
PI 3-kinase assay
Activation of PI 3-kinase was determined in extracts of control and insulin-stimulated tissues using methods described previously (15) , namely, measurement of PI 3-kinase activity in IRS-1 immunoprecipitates.
Western analyses
Tissues were examined for levels of immunoreactive GLUT4, GLUT1, PKC␣, PKC␤1, PKC␤2, total PKC␤1ϩ␤2, PKC␦, PKC⑀, and PKC as previosuly described (4 -6) . Except for the anti-PKC␤1ϩ2 antiserum [a polyclonal antiserum raised against an epitope in the C3 region in the catalytic domain; described previously (5)] and the PKC␤1 antiserum (raised against a C-terminal V5 epitope; provided by Dr. Mildred Acevedo-Duncan), anti-PKC polyclonal antisera were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-GLUT4 polyclonal antiserum was purchased from Biogenesis (Sandown, NH). Anti-GLUT1 polyclonal antiserum was provided by Dr. Ian Simpson, NIH. Anti IRS-1 polyclonal antiserum was provided by Dr. Alan Saltiel, Parke-Davis (Ann Arbor, MI). Anti-HA mouse monoclonal antibody was purchased from Covance (Berkeley, CA). Levels of immunoreactivity were quantitated by measurement of chemiluminescence in a Bio-Rad Chemiluminescence/ 32 P Molecular Analyst Imaging System (Bio-Rad Labora-
Results

Comparison of serum glucose and insulin levels in offspring of extensively back-crossed heterozygous PKC␤b ϩ/Ϫ mice
Initially, mice were examined in which genetic differences, other than the absence of the PKC␤ gene, were minimized by repeated backcrossing of heterozygous PKC␤ ϩ/Ϫ mice with normal PKC␤ ϩ/ϩ C57BL/6 mice. Offspring of subsequently derived heterozygous breeding pairs were then typed by Southern analysis and/or for levels of skeletal muscle immunoreactive PKC␤ (full, intermediate, or absent), and their serum levels of glucose and insulin were examined. As shown in Table 1 , fasting serum glucose levels were approximately 10% lower, but not statistically different, in PKC␤ knockout mice (PKC␤ Ϫ/Ϫ ) compared with those in their PKC␤ ϩ/ϩ littermates despite similar or slightly lower insulin levels. Similarly, after ip glucose (1 mg/g BW) administration, serum glucose levels in PKC␤ Ϫ/Ϫ male mice were 10% less than those in PKC␤ ϩ/ϩ male mice (P Ͻ 0.05) despite slightly lower, albeit not significantly, insulin levels. These findings indicated that overall glucose homeostasis was mildly, but significantly, enhanced in mice in which the PKC␤ gene was knocked out by homologous recombination. These findings also suggested that glucose metabolism or insulin action, rather than insulin secretion, may be enhanced in PKC␤ knockout mice.
Unfortunately, this backcrossing approach, although in theory preferable, did not provide sufficient members of PKC␤ Ϫ/Ϫ and PKC␤ ϩ/ϩ mice for direct comparisons, and subsequent studies were conducted in which PKC␤ Ϫ/Ϫ mice were compared with commercially obtained control PKC␤ ϩ/ϩ mice (see Materials and Methods).
Comparison of serum glucose and insulin levels in various PKC␤ knockout mice and various commercially available control mice
Fasting and fed (ad libitum) serum glucose levels were not significantly different when PKC␤ knockout mice were compared with commercially available control mice with a similar genetic background, i.e. as C57BL/6 -129/SV hybrids (Table 2) . Similarly, fasting serum glucose levels were not significantly different when the PKC␤ knockout mice were compared with controls that were pure strains of C57BL/6 mice ( Table 2) . Control 129/SV mice, on the other hand, had lower fasting serum glucose levels. Of particular importance, fasting serum insulin levels were lowest in PKC␤ knockout mice (Table 2) .
Similar serum glucose/insulin patterns were observed after ip injection of glucose (Table 2) , i.e. serum glucose levels were similar in PKC␤ knockout, C57BL/6, and C57BL/6 -129/SV hybrid mice; serum glucose values were lowest in 129/SV mice; and serum insulin levels were lowest in PKC␤ knockout mice. Increases in serum glucose levels were surprisingly high, and increases in serum insulin levels were relatively small in all mouse strains after ip injection of glucose; this apparently limited insulin response may reflect the effects of stress and/or a need for gut incretins to stimulate insulin secretion more effectively. In support of the latter explanation, higher serum insulin levels were observed along with lower serum glucose levels in fed mice ( Table 2) . Regardless of the cause of the lesser insulin response to ip glucose administration, it is clear that serum insulin levels, relative to serum glucose levels, were not increased in PKC␤ knockout mice regardless of whether the mice were fasting, fed, or challenged with ip glucose.
2-DOG uptake in adipocytes and soleus muscles in vitro
As shown in Fig. 1 , insulin-stimulated, but not basal, [ 3 H]2-DOG uptake was increased in adipocytes prepared from PKC␤ knockout mice compared with 2-DOG uptake in adipocytes of C57BL/6 -129/SV hybrid, C57BL/6, or 129/SV mice; the major change appeared to be an increase in the maximal rate of 2-DOG uptake, with no change in insulin sensitivity. As shown in Fig. 2 , results were somewhat different in soleus muscles. 2-DOG uptake was mildly, but significantly, increased in the basal state, and this appeared to largely account for increases observed during insulin treatment in muscles of PKC␤ knockout mice compared with those of C57BL/6 -129/SV hybrid mice.
2-DOG uptake in skeletal muscle in vivo
Similar to findings in in vitro studies, 2-DOG uptake in the gastrocnemius muscle of PKC␤ knockout mice was slightly, but not significantly, higher both basally and during insulin treatment in vivo (Fig. 2) . Blood glucose levels decreased from 140 to 45 mg/dl in both groups of mice over the course of the 15-min insulin treatment period in vivo, and kinetic information at earlier time points was not apparent in this study. Nevertheless, these findings provided clear evidence that insulin-stimulated hexose transport and subsequent phosphorylation (and thus trapping of 2-DOG-6-PO 4 ) were not compromised in gastrocnemius muscles of PKC␤ knockout mice.
Activation of PI 3-kinase in skeletal muscle in vivo
Insulin provoked increases in IRS-1-dependent PI 3-kinase activity in adipocytes (Fig. 3 ) and gastrocnemius muscles (Fig. 2) of PKC␤ knockout mice that were not significantly different from the increases observed in control mice. These results suggested that initial steps of signaling in this pathway in response to maximally effective doses of insulin were not significantly altered in adipocytes and skeletal muscles of PKC␤ knockout mice.
Western analyses
Immunoreactive PKC␤, measured as PKC␤1, PKC␤2, or total PKC␤1 plus ␤2, was undetectable in tissues of PKC␤ knockout mice (Fig. 4) . In contrast, levels of other PKCs (␣, ␦, ⑀, and ) were comparable in insulin-sensitive tissues, including liver, adipocytes, and skeletal muscles of PKC␤ knockout mice and control mice (Fig. 5) . Similarly, levels of GLUT4 and GLUT1 glucose transporters were not significantly different in adipocytes and skeletal muscles of PKC␤ knockout and control mice (see Fig. 4 and Table 3 ).
FIG. 1. Effects of knockout of the PKC␤ gene on [
3 H]2-DOG uptake in rat adipocytes (A) and soleus muscles (B). A, In each adipocyte experiment, cells were prepared simultaneously from PKC␤ knockout mice (C57BL/6 -129/SV hybrids) and the indicated strains of control mice and then incubated with the indicated concentrations of insulin as described in Materials and Methods. Values are the mean Ϯ SE of the determinations shown in parentheses. B, Soleus muscles were incubated for 30 min with or without 100 nM insulin as indicated before measurement of 2-DOG uptake as described in Materials and Methods. Note that each insulin-treated muscle was compared with its own control (a), and we simultaneously compared muscles from PKC␤ knockout mice and control mice (b; all C57BL/6 -129/SV hybrids) in each experiment. Values are the mean Ϯ SE of the number of determinations shown in parentheses. P was determined by standard t test.
Glucose tolerance testing
Blood glucose levels (which were approximately 50% less than serum glucose levels) were virtually the same in PKC␤ knockout and control mice (C57BL/6 -129/SV hybrids) at zero time and at 10, 30, and 60 min after ip injection of glucose (2 mg/g BW; Fig. 6 ).
Effects of knockout of PKC␤ on HA-GLUT4 translocation
In keeping with the finding of enhanced 2-DOG uptake in cells and tissues of PKC␤ knockout mice, the translocation of HA-tagged GLUT4 to the plasma membrane was increased in adipocytes of PKC␤ knockout mice, both basally and in response to insulin (Fig. 7) . The significance of increases in basal GLUT4 translocation, however, is uncertain, as such basal GLUT4 translocation and glucose transport activity may have been increased as a result of electroporation and overnight culturing, and this artifactual increase may have been exaggerated in the more active PKC␤ knockout adipocyte. 3 . Activation of PI 3-kinase in adipocytes of PKC␤ knockout and control mice. Adipocytes were prepared from control and PKC␤ knockout mice (all C57BL/6 -129/SV hybrids) and incubated for 15 min in glucose-free KRP medium with or without 10 nM insulin as indicated. Adipocytes were then homogenized, and 500 g lysate protein were subjected to precipitation with anti-IRS-1 antiserum and subsequent assay of associated PI 3-kinase activity (see Materials and Methods). Shown at the left is a representative autoradiogram of TLC-resolved lipid products of the PI 3-kinase assay. Bar graphs shown at the right portray the mean Ϯ SE values of four determinations. P was determined by standard t test. 
Effects of transfected PKC␤1 and PKC␤2 on HA-GLUT4 translocation
Our findings raised the possibility that PKC␤1 and/or PKC␤2 may have an inhibitory effect on glucose transport in insulin-sensitive tissues. This possibility was further evaluated by transiently expressing HA-tagged GLUT4 and either PKC␤1 or PKC␤2 in adipocytes of PKC␤ knockout mice. As shown in Fig. 7 , the expression of PKC␤1, but not PKC␤2, resulted in 33% inhibition of insulin-stimulated, but not basal, HA-GLUT4 translocation, despite the fact that expression of PKC␤2 was greater than that of PKC␤1. These findings suggested that PKC␤1 might exert an inhibitory effect on the glucose transport process.
Discussion
It seems clear that regardless of which control group was used for comparison, overall glucose homeostasis was not impaired in PKC␤ knockout mice. In fact, in littermates in which genetic differences other than absence of the PKC␤ gene were minimized by repeated backcrossing of heterozygote PKC␤ knockout mice in control C57BL/6 mice, serum glucose levels were approximately 10% lower in homozygous PKC␤ Ϫ/Ϫ offspring compared with wild-type PKC␤ ϩ/ϩ offspring both in the fasting state and, more significantly, after ip glucose injection despite comparable or slightly lower serum insulin levels. Accordingly, from findings in backcrossed offspring, it may be surmised that PKC␤ knockout mice were, if anything, more glucose tolerant than control mice. Serum insulin levels were not elevated and, moreover, in some cases they appeared to be slightly lower in PKC␤ knockout mice; clearly, PKC␤ knockout mice were not insulin resistant. Moreover, the finding that blood glucose levels were slightly lower in PKC␤ Ϫ/Ϫ knockout mice than in their littermate PKC␤ ϩ/ϩ controls (in the face of similar or lower insulin levels) suggested that the absence of the PKC␤ gene and its splice products, PKB-␤1 and PKC␤2, caused either an increase in sensitivity to insulin or an alteration in insulin-independent glucose metabolism, e.g. decreased hepatic glucose output or enhanced glucose disposal. In keeping with the possibility of enhanced glucose disposal, glucose transport was enhanced in adipocytes and skeletal muscle preparations in PKC␤ knockout mice, and translocation of HA-tagged GLUT4 was increased in adipocytes of PKC␤ knockout mice.
The reason for presently observed increases in glucose transport in adipocytes and soleus muscles, and GLUT4 translocation in adipocytes, of PKC␤ knockout mice was uncertain. We did not detect significant differences in the overall activation of PI 3-kinase in adipocytes and skeletal muscle, and levels of GLUT4 and GLUT1 glucose transporters were not significantly different in skeletal muscles and adipocytes of control and PKC␤ knockout mice. Although we did not presently study insulin receptor activation, diminished activation of insulin receptor tyrosine kinase has been reported during both phorbol ester-induced activation of PKC␤ and other DAG-sensitive kinases in rat adipocytes and other cells (7) (8) (9) and after transfection of PKC␤1 and PKC␤2 into HEK 293 cells (1) . We cannot exclude the possibility that increases in glucose transport in PKC␤ knockout mice may have reflected enhanced signaling at the level of the insulin receptor despite the fact that we did not observe significant increases in IRS-1-dependent PI 3-kinase activation. However, it seems more plausible to suggest that signaling processes different from or subsequent to PI 3-kinase activation may have been enhanced in PKC␤ knockout mice. It also seems likely that these enhanced signaling processes resulted in increases in the translocation of GLUT4 glucose transporters, at least in adipocytes, in PKC␤ knockout mice. Further studies will be required to determine the exact reason(s) for increases in glucose transport in adipocytes and soleus muscles of PKC␤ knockout mice.
Whereas our studies did not identify the signaling factor Samples containing equal amounts of cellular lysates from tissues of both control (C57BL/6-129/SV) and PKC␤ knockout mice were analyzed simultaneously on the same blot. Levels of immunoreactivity were determined by comparing each sample to the mean control value observed on the same blot. Values are the mean Ϯ SE of the number of determinations given in parentheses.
that was responsible for increases in glucose transport in PKC␤ knockout mice, our "knockin" studies in adipocytes of PKC␤ knockout mice suggested that PKC␤1 is more likely than PKC␤2 to serve as a negative modulator of insulinstimulated GLUT4 translocation. Interestingly, we found (16) that transient overexpression of PKC␤1, but not PKC␤2, also inhibits HA-GLUT4 translocation in adipocytes of normal rats. The apparent selectivity of PKC␤1 as a negative modulator of insulin-stimulated glucose transport merits further study.
Although our findings demonstrated that insulin readily stimulates glucose transport in the complete absence of both PKC␤ and PKC␤2, it may be argued that findings in PKC␤ knockout mice may not be relevant to the situation in mice that have normal amounts of PKC␤ and other signaling factors. For example, it is possible that the absence of the functional PKC␤ gene may have caused other signaling factors to hypertrophy. However, we did not observe increases in levels of other PKCs or in GLUT4 or GLUT1 glucose transporters in PKC␤ knockout mice. Furthermore, the present finding of uncompromised insulin action in PKC␤ knockout mice is in accord with findings in studies in which PKC␤ was acutely inhibited or markedly depleted in various types of otherwise normal cells (4 -6, 17, 18) . As another possibility, it could be argued that normal or wild-type cells have redundant signaling pathways and kinases that participate in activating glucose transport, including PKC␤2, atypical PKCs, PKC and PKC, PKB, and/or PKN; thus, the loss of a single kinase would not compromise the effects of insulin on glucose transport. This possibility, however, seems unlikely, as transient expression of kinase-inactive PKC or PKC, but not kinase-inactive PKC␤2, markedly inhibits epitope-tagged GLUT4 translocation in rat adipocytes (6, 16) . Taken together, the present and several other independent lines of evidence lead us to conclude that PKC␤ is not required for insulin stimulation of glucose transport.
In summary, our findings in PKC␤ knockout mice provide clear evidence that PKC␤2 or PKC␤1 cannot be considered to be essential for insulin stimulation of glucose transport in mouse tissues. Moreover, overall glucose homeostasis in vivo FIG. 7 . Effects of knockout of the PKC␤ gene (A) and expression of PKC␤1 and PKC␤2 in adipocytes of PKC␤ knockout mice (B) on control and insulin-stimulated HA-GLUT4 translocation in transiently transfected adipocytes. All adipocytes (from normal wild-type C57BL/6 -129/SV or PKC␤ knockout C57BL/6 -129/SV mice) were transfected with pCIS2 containing cDNA encoding HA-GLUT4 without (A) or with (B) pTB701 containing no insert (Vector) or cDNA insert encoding PKC␤1 or PKC␤2. After overnight incubation to allow time for expression of HA-GLUT4, PKC␤1, and PKC␤2 (see blots at the right), cells were treated for 30 min with or without 10 nM insulin as indicated and examined for translocation of HA-GLUT4 to the plasma membrane as described in Materials and Methods. In A and B, the levels of immunoreactive HA-GLUT4 were evaluated by blotting with mouse monoclonal anti-HA antibody. In B, levels of immunoreactive PKC␤1 and PKC␤2 in transfected knockout (KO) cells were directly compared with each other and to levels in wild-type cells using an antiserum that recognizes an epitope in the C3 region that is common to both 80-kDa splice products of the PKC␤ gene; as is apparent, the expression of PKC␤2 was greater than that of PKC␤1. As described previously (6) , only approximately 5% of cells are transfected with the present electroporation method, and the levels of immunoreactive PKC␤1 and PKC␤2 observed in transfected knockout cells, despite being less than those observed in cell extracts obtained from equal amounts of wild-type nonknockout cells, are, nevertheless, quite sizable when considered on the basis of the percentage of transfected cells. Values in bar graphs are the mean Ϯ SE of four determinations. P was determined by standard t test.
and glucose transport in two tissues that are largely dependent upon GLUT4 translocation during insulin stimulation, viz. adipocytes and soleus muscles, were significantly enhanced in PKC␤ knockout mice. Our findings therefore suggest that selective PKC␤ inhibitors are unlikely to adversely affect insulin action and overall glucose homeostasis; indeed, in view of the present findings, the opposite result may be observed with PKC␤ inhibitors, i.e. there may be increases in insulin action and glucose tolerance. Determining whether such inhibitors will adversely affect other functions remains for future studies.
